Secukinumab B
Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IL Receptor
CAS Number
1229022-83-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx492136-01 96 Tests
Mouse Proteinase-Activated Receptor 2 / PAR2 (F2RL1) CLIA Kit
Ask
View Details 
abx492136-02 5x 96 Tests
Mouse Proteinase-Activated Receptor 2 / PAR2 (F2RL1) CLIA Kit
Ask
View Details abx492136-03 10x 96 Tests
Mouse Proteinase-Activated Receptor 2 / PAR2 (F2RL1) CLIA Kit
Ask
View Details